Eversept Partners’s Medtronic MDT Stock Holding History

Eversept Partners’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-26,800	Closed	-$2.65M	–	61
2018 Q3	$2.65M	Buy	+26,800	New	+$2.48M	1.16%	19

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Eversept Partners's MDT Position: Q4 2018 in Review

Eversept Partners sold out of Medtronic (MDT) in Q4 2018, closing a stake of 26,800 shares — an estimated $2.65M sold.

Eversept Partners first reported a position in MDT in Q3 2018 and held it in 1 quarter. The position peaked at $2.65M in Q3 2018. 1,564 funds tracked by Wall St. Rank hold MDT as of Q4 2018.

Eversept Partners reported no remaining Medtronic position as of Q4 2018 after selling out during the quarter.
Eversept Partners sold 26,800 Medtronic shares in Q4 2018, an estimated $2.65M.
Eversept Partners first reported a position in Medtronic in Q3 2018 and held it in 1 quarter.
Eversept Partners's Medtronic position peaked at $2.65M in Q3 2018.
1,564 funds tracked by Wall St. Rank held Medtronic as of Q4 2018.

Based on Eversept Partners's 13F filing for Q4 2018, filed 13 Feb 2019.